| Published in | Pharmaceutical Science and Technology (Volume 1, Issue 1) |
| DOI | 10.11648/j.pst.20170101.12 |
| Page(s) | 4-5 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2016. Published by Science Publishing Group |
| [1] | Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians, 2016; 66: 7-30. |
| [2] | Livingston RB. Single agents in cancer chemotherapy. Springer Science & Business Media 2012. |
| [3] | Vanneman M, Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nature Reviews Cancer, 2012; 12: 237-251. |
| [4] | Plenderleith IH. Treating the treatment: toxicity of cancer chemotherapy. Canadian Family Physician, 1990; 36: 1827. |
| [5] | Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. Journal of Controlled Release, 2011; 153: 198. |
| [6] | Lee S-H, Roichman Y, Yi G-R, Kim S-H, Yang S-M, van Blaaderen A, van Oostrum P, Grier DG. Characterizing and tracking single colloidal particles with video holographic microscopy. Optics Express, 2007; 15: 18275-18282. |
| [7] | Wang C, Zhong X, Ruffner DB, Stutt A, Philips LA, Ward MD, Grier DG. Holographic characterization of protein aggregates. Journal of pharmaceutical sciences, 2016; 105: 1074-1085. |
| [8] | Fenske DB, Chonn A, Cullis PR. Liposomal nanomedicines: an emerging field. Toxicologic pathology, 2008; 36: 21-29. |
| [9] | Kang C, Sun Y, Wang M, Cheng X. Nanosized Camptothecin Conjugates for Single and Combined Drug Delivery. European Journal of BioMedical Research, 2016; 2: 8-14. |
| [10] | Kim SH, Kaplan JA, Sun Y, Shieh A, Sun HL, Croce CM, Grinstaff MW, Parquette JR. The Self‐Assembly of Anticancer Camptothecin–Dipeptide Nanotubes: A Minimalistic and High Drug Loading Approach to Increased Efficacy. Chemistry–A European Journal, 2015; 21: 101-105. |
| [11] | Sun Y, Kaplan JA, Shieh A, Sun H-L, Croce CM, Grinstaff MW, Parquette JR. Self-assembly of a 5-fluorouracil-dipeptide hydrogel. Chemical Communications, 2016; 52: 5254-5257. |
| [12] | Green M, Manikhas G, Orlov S, Afanasyev B, Makhson A, Bhar P, Hawkins M. Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Annals of Oncology, 2006; 17: 1263-1268. |
| [13] | Linkov I, Satterstrom FK, Corey LM. Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine: Nanotechnology, Biology and Medicine, 2008; 4: 167-171. |
APA Style
Yuan Sun, Xiao Zhong, Chen Kang. (2016). Nanomedicine for Treatment of Cancer. Pharmaceutical Science and Technology, 1(1), 4-5. https://doi.org/10.11648/j.pst.20170101.12
ACS Style
Yuan Sun; Xiao Zhong; Chen Kang. Nanomedicine for Treatment of Cancer. Pharm. Sci. Technol. 2016, 1(1), 4-5. doi: 10.11648/j.pst.20170101.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.pst.20170101.12,
author = {Yuan Sun and Xiao Zhong and Chen Kang},
title = {Nanomedicine for Treatment of Cancer},
journal = {Pharmaceutical Science and Technology},
volume = {1},
number = {1},
pages = {4-5},
doi = {10.11648/j.pst.20170101.12},
url = {https://doi.org/10.11648/j.pst.20170101.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.pst.20170101.12},
abstract = {},
year = {2016}
}
TY - JOUR T1 - Nanomedicine for Treatment of Cancer AU - Yuan Sun AU - Xiao Zhong AU - Chen Kang Y1 - 2016/06/17 PY - 2016 N1 - https://doi.org/10.11648/j.pst.20170101.12 DO - 10.11648/j.pst.20170101.12 T2 - Pharmaceutical Science and Technology JF - Pharmaceutical Science and Technology JO - Pharmaceutical Science and Technology SP - 4 EP - 5 PB - Science Publishing Group SN - 2640-4540 UR - https://doi.org/10.11648/j.pst.20170101.12 AB - VL - 1 IS - 1 ER -
Information
Email: